{"id":"NCT01451541","sponsor":"Sumitomo Pharma America, Inc.","briefTitle":"A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).","officialTitle":"A 12-Week Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2012-12","completion":"2012-12","firstPosted":"2011-10-13","resultsPosted":"2014-05-06","lastUpdate":"2014-05-06"},"enrollment":848,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Perennial Allergic Rhinitis","PAR"],"interventions":[{"type":"DRUG","name":"Ciclesonide nasal aerosol 37 mcg","otherNames":[]},{"type":"DRUG","name":"ciclesonide nasal aerosol 74 mcg","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"ciclesonide nasal aerosol 37mcg","type":"ACTIVE_COMPARATOR"},{"label":"ciclesonide nasal aerosol 74 mcg","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This is a 12-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group, efficacy and safety study of ciclesonide nasal aerosol administered once daily to male and premenarchal female subjects 6 to 11 years of age with a diagnosis of PAR.","primaryOutcome":{"measure":"The Change From Baseline in Average Daily Subject-reported AM and PM Reflective Total Nasal Symptom Scores (rTNSS) Averaged Weekly Over the First 6 Weeks of the Double-blind Treatment.","timeFrame":"Weeks 0-6","effectByArm":[{"arm":"Placebo","deltaMin":-1.51,"sd":0.13},{"arm":"Ciclesonide Nasal Aerosol 37mcg","deltaMin":-2.1,"sd":0.13},{"arm":"Ciclesonide Nasal Aerosol 74 mcg","deltaMin":-1.98,"sd":0.131}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.05"},{"comp":"OG000 vs OG002","p":"<0.05"}]},"eligibility":{"minAge":"6 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":17},"locations":{"siteCount":60,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":283},"commonTop":["HEADACHE","EPISTAXIS","UPPER RESPIRATORY TRACT INFECTION","COUGH","PYREXIA"]}}